nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—ADRA2A—type 2 diabetes mellitus	0.103	0.325	CbGaD
Mirtazapine—HTR2C—type 2 diabetes mellitus	0.0951	0.299	CbGaD
Mirtazapine—CYP1A2—type 2 diabetes mellitus	0.0717	0.226	CbGaD
Mirtazapine—CYP3A4—type 2 diabetes mellitus	0.0475	0.15	CbGaD
Mirtazapine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0276	0.0648	CbGbCtD
Mirtazapine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0269	0.063	CbGbCtD
Mirtazapine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0217	0.0508	CbGbCtD
Mirtazapine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.02	0.0469	CbGbCtD
Mirtazapine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0193	0.0452	CbGbCtD
Mirtazapine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0166	0.0389	CbGbCtD
Mirtazapine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0141	0.033	CbGbCtD
Mirtazapine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0133	0.0313	CbGbCtD
Mirtazapine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0133	0.0311	CbGbCtD
Mirtazapine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0127	0.0298	CbGbCtD
Mirtazapine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0127	0.0298	CbGbCtD
Mirtazapine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0122	0.0286	CbGbCtD
Mirtazapine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0274	CbGbCtD
Mirtazapine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0107	0.025	CbGbCtD
Mirtazapine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00964	0.0226	CbGbCtD
Mirtazapine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0093	0.0218	CbGbCtD
Mirtazapine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0089	0.0209	CbGbCtD
Mirtazapine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00859	0.0202	CbGbCtD
Mirtazapine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00851	0.0199	CbGbCtD
Mirtazapine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00791	0.0185	CbGbCtD
Mirtazapine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00701	0.0164	CbGbCtD
Mirtazapine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00689	0.0162	CbGbCtD
Mirtazapine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00672	0.0158	CbGbCtD
Mirtazapine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00672	0.0158	CbGbCtD
Mirtazapine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00621	0.0146	CbGbCtD
Mirtazapine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00615	0.0144	CbGbCtD
Mirtazapine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00607	0.0142	CbGbCtD
Mirtazapine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00599	0.0141	CbGbCtD
Mirtazapine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00567	0.0133	CbGbCtD
Mirtazapine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00548	0.0129	CbGbCtD
Mirtazapine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00542	0.0127	CbGbCtD
Mirtazapine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00541	0.0127	CbGbCtD
Mirtazapine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00513	0.012	CbGbCtD
Mirtazapine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0051	0.012	CbGbCtD
Mirtazapine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00495	0.0116	CbGbCtD
Mirtazapine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00489	0.0115	CbGbCtD
Mirtazapine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00466	0.0109	CbGbCtD
Mirtazapine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00451	0.0106	CbGbCtD
Mirtazapine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00447	0.0105	CbGbCtD
Mirtazapine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00432	0.0101	CbGbCtD
Mirtazapine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00391	0.00917	CbGbCtD
Mirtazapine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00349	0.00819	CbGbCtD
Mirtazapine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00344	0.00807	CbGbCtD
Mirtazapine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00315	0.00738	CbGbCtD
Mirtazapine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00296	0.00695	CbGbCtD
Mirtazapine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00284	0.00666	CbGbCtD
Mirtazapine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00284	0.00666	CbGbCtD
Mirtazapine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00269	0.0063	CbGbCtD
Mirtazapine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00201	0.0709	CbGeAlD
Mirtazapine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.002	0.00469	CbGbCtD
Mirtazapine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00194	0.0683	CbGeAlD
Mirtazapine—HTR2A—arteriole—type 2 diabetes mellitus	0.00189	0.0669	CbGeAlD
Mirtazapine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00183	0.00429	CbGbCtD
Mirtazapine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00135	0.0476	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.0013	0.0459	CbGeAlD
Mirtazapine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00121	0.0426	CbGeAlD
Mirtazapine—HTR3A—nerve—type 2 diabetes mellitus	0.00113	0.0399	CbGeAlD
Mirtazapine—SLC6A3—nerve—type 2 diabetes mellitus	0.000941	0.0332	CbGeAlD
Mirtazapine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000939	0.0331	CbGeAlD
Mirtazapine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000811	0.0286	CbGeAlD
Mirtazapine—SLC6A2—nerve—type 2 diabetes mellitus	0.000759	0.0268	CbGeAlD
Mirtazapine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00075	0.0265	CbGeAlD
Mirtazapine—HTR7—artery—type 2 diabetes mellitus	0.000738	0.026	CbGeAlD
Mirtazapine—HTR7—nerve—type 2 diabetes mellitus	0.000732	0.0258	CbGeAlD
Mirtazapine—DRD2—nerve—type 2 diabetes mellitus	0.000692	0.0244	CbGeAlD
Mirtazapine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000688	0.0243	CbGeAlD
Mirtazapine—HTR7—endothelium—type 2 diabetes mellitus	0.000623	0.022	CbGeAlD
Mirtazapine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000585	0.0207	CbGeAlD
Mirtazapine—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000548	0.0193	CbGeAlD
Mirtazapine—HTR2A—artery—type 2 diabetes mellitus	0.00046	0.0162	CbGeAlD
Mirtazapine—HTR2A—nerve—type 2 diabetes mellitus	0.000456	0.0161	CbGeAlD
Mirtazapine—HTR2A—endothelium—type 2 diabetes mellitus	0.000389	0.0137	CbGeAlD
Mirtazapine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000313	0.011	CbGeAlD
Mirtazapine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000299	0.0106	CbGeAlD
Mirtazapine—Epinastine—ADRA2A—type 2 diabetes mellitus	0.000291	0.202	CrCbGaD
Mirtazapine—DRD2—retina—type 2 diabetes mellitus	0.000287	0.0101	CbGeAlD
Mirtazapine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000285	0.0101	CbGeAlD
Mirtazapine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000276	0.00973	CbGeAlD
Mirtazapine—Metixene—HTR2C—type 2 diabetes mellitus	0.00027	0.187	CrCbGaD
Mirtazapine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000268	0.00947	CbGeAlD
Mirtazapine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000264	0.00932	CbGeAlD
Mirtazapine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000262	0.00926	CbGeAlD
Mirtazapine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.00026	0.00918	CbGeAlD
Mirtazapine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000256	0.00905	CbGeAlD
Mirtazapine—HTR7—kidney—type 2 diabetes mellitus	0.000251	0.00885	CbGeAlD
Mirtazapine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000247	0.00873	CbGeAlD
Mirtazapine—Azatadine—CYP3A4—type 2 diabetes mellitus	0.000231	0.16	CrCbGaD
Mirtazapine—ADRA2C—kidney—type 2 diabetes mellitus	0.000231	0.00814	CbGeAlD
Mirtazapine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000229	0.00808	CbGeAlD
Mirtazapine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000225	0.00793	CbGeAlD
Mirtazapine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000218	0.0077	CbGeAlD
Mirtazapine—CYP2C8—kidney—type 2 diabetes mellitus	0.000214	0.00755	CbGeAlD
Mirtazapine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000208	0.00733	CbGeAlD
Mirtazapine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000194	0.00685	CbGeAlD
Mirtazapine—HTR2A—retina—type 2 diabetes mellitus	0.000189	0.00667	CbGeAlD
Mirtazapine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000183	0.00645	CbGeAlD
Mirtazapine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000179	0.00632	CbGeAlD
Mirtazapine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000169	0.00596	CbGeAlD
Mirtazapine—Mianserin—ADRA2A—type 2 diabetes mellitus	0.000168	0.117	CrCbGaD
Mirtazapine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000166	0.00585	CbGeAlD
Mirtazapine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.00016	0.00564	CbGeAlD
Mirtazapine—HTR7—liver—type 2 diabetes mellitus	0.000159	0.0056	CbGeAlD
Mirtazapine—HTR2A—kidney—type 2 diabetes mellitus	0.000156	0.00552	CbGeAlD
Mirtazapine—Mianserin—HTR2C—type 2 diabetes mellitus	0.000155	0.107	CrCbGaD
Mirtazapine—ADRA1A—liver—type 2 diabetes mellitus	0.000153	0.0054	CbGeAlD
Mirtazapine—ADRA2C—liver—type 2 diabetes mellitus	0.000146	0.00514	CbGeAlD
Mirtazapine—CYP3A4—kidney—type 2 diabetes mellitus	0.000145	0.00511	CbGeAlD
Mirtazapine—CYP2D6—kidney—type 2 diabetes mellitus	0.000142	0.00503	CbGeAlD
Mirtazapine—CYP2C8—liver—type 2 diabetes mellitus	0.000135	0.00477	CbGeAlD
Mirtazapine—Epinastine—CYP3A4—type 2 diabetes mellitus	0.000134	0.0927	CrCbGaD
Mirtazapine—CYP1A2—liver—type 2 diabetes mellitus	0.000126	0.00446	CbGeAlD
Mirtazapine—CYP2C9—liver—type 2 diabetes mellitus	0.00012	0.00424	CbGeAlD
Mirtazapine—Mianserin—CYP1A2—type 2 diabetes mellitus	0.000117	0.081	CrCbGaD
Mirtazapine—HTR2A—liver—type 2 diabetes mellitus	9.89e-05	0.00349	CbGeAlD
Mirtazapine—CYP3A4—liver—type 2 diabetes mellitus	9.15e-05	0.00323	CbGeAlD
Mirtazapine—CYP2D6—liver—type 2 diabetes mellitus	9.01e-05	0.00318	CbGeAlD
Mirtazapine—Mianserin—CYP3A4—type 2 diabetes mellitus	7.73e-05	0.0536	CrCbGaD
Mirtazapine—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.000361	CcSEcCtD
Mirtazapine—Shock—Metformin—type 2 diabetes mellitus	4.99e-05	0.000361	CcSEcCtD
Mirtazapine—Insomnia—Orlistat—type 2 diabetes mellitus	4.98e-05	0.00036	CcSEcCtD
Mirtazapine—Malaise—Losartan—type 2 diabetes mellitus	4.97e-05	0.00036	CcSEcCtD
Mirtazapine—Anxiety—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.00036	CcSEcCtD
Mirtazapine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.97e-05	0.00036	CcSEcCtD
Mirtazapine—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.97e-05	0.00036	CcSEcCtD
Mirtazapine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.96e-05	0.000359	CcSEcCtD
Mirtazapine—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.96e-05	0.000359	CcSEcCtD
Mirtazapine—Vertigo—Losartan—type 2 diabetes mellitus	4.96e-05	0.000359	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000359	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.95e-05	0.000359	CcSEcCtD
Mirtazapine—Somnolence—Valsartan—type 2 diabetes mellitus	4.95e-05	0.000358	CcSEcCtD
Mirtazapine—Syncope—Losartan—type 2 diabetes mellitus	4.95e-05	0.000358	CcSEcCtD
Mirtazapine—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.94e-05	0.000358	CcSEcCtD
Mirtazapine—Leukopenia—Losartan—type 2 diabetes mellitus	4.94e-05	0.000358	CcSEcCtD
Mirtazapine—Discomfort—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000357	CcSEcCtD
Mirtazapine—Skin disorder—Metformin—type 2 diabetes mellitus	4.92e-05	0.000357	CcSEcCtD
Mirtazapine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.9e-05	0.000355	CcSEcCtD
Mirtazapine—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.9e-05	0.000355	CcSEcCtD
Mirtazapine—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.88e-05	0.000353	CcSEcCtD
Mirtazapine—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.88e-05	0.000353	CcSEcCtD
Mirtazapine—Palpitations—Losartan—type 2 diabetes mellitus	4.87e-05	0.000353	CcSEcCtD
Mirtazapine—Nausea—Glimepiride—type 2 diabetes mellitus	4.86e-05	0.000352	CcSEcCtD
Mirtazapine—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000352	CcSEcCtD
Mirtazapine—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.85e-05	0.000351	CcSEcCtD
Mirtazapine—Nausea—Sitagliptin—type 2 diabetes mellitus	4.84e-05	0.000351	CcSEcCtD
Mirtazapine—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.84e-05	0.000351	CcSEcCtD
Mirtazapine—Asthenia—Glyburide—type 2 diabetes mellitus	4.84e-05	0.000351	CcSEcCtD
Mirtazapine—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.84e-05	0.00035	CcSEcCtD
Mirtazapine—Anorexia—Metformin—type 2 diabetes mellitus	4.83e-05	0.00035	CcSEcCtD
Mirtazapine—Cough—Losartan—type 2 diabetes mellitus	4.81e-05	0.000349	CcSEcCtD
Mirtazapine—Urticaria—Gliclazide—type 2 diabetes mellitus	4.81e-05	0.000349	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.81e-05	0.000348	CcSEcCtD
Mirtazapine—Alopecia—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000348	CcSEcCtD
Mirtazapine—Fatigue—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000348	CcSEcCtD
Mirtazapine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000347	CcSEcCtD
Mirtazapine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000347	CcSEcCtD
Mirtazapine—Oedema—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000346	CcSEcCtD
Mirtazapine—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000346	CcSEcCtD
Mirtazapine—Pruritus—Glyburide—type 2 diabetes mellitus	4.77e-05	0.000346	CcSEcCtD
Mirtazapine—Mental disorder—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000345	CcSEcCtD
Mirtazapine—Constipation—Valsartan—type 2 diabetes mellitus	4.76e-05	0.000345	CcSEcCtD
Mirtazapine—Infection—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000344	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.75e-05	0.000344	CcSEcCtD
Mirtazapine—Fatigue—Orlistat—type 2 diabetes mellitus	4.74e-05	0.000343	CcSEcCtD
Mirtazapine—Hypotension—Metformin—type 2 diabetes mellitus	4.74e-05	0.000343	CcSEcCtD
Mirtazapine—Malnutrition—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000343	CcSEcCtD
Mirtazapine—Shock—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000341	CcSEcCtD
Mirtazapine—Pain—Orlistat—type 2 diabetes mellitus	4.7e-05	0.000341	CcSEcCtD
Mirtazapine—Myalgia—Losartan—type 2 diabetes mellitus	4.7e-05	0.00034	CcSEcCtD
Mirtazapine—Chest pain—Losartan—type 2 diabetes mellitus	4.7e-05	0.00034	CcSEcCtD
Mirtazapine—Arthralgia—Losartan—type 2 diabetes mellitus	4.7e-05	0.00034	CcSEcCtD
Mirtazapine—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.69e-05	0.00034	CcSEcCtD
Mirtazapine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.00034	CcSEcCtD
Mirtazapine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000339	CcSEcCtD
Mirtazapine—Anxiety—Losartan—type 2 diabetes mellitus	4.68e-05	0.000339	CcSEcCtD
Mirtazapine—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000338	CcSEcCtD
Mirtazapine—Rash—Bromocriptine—type 2 diabetes mellitus	4.65e-05	0.000337	CcSEcCtD
Mirtazapine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.65e-05	0.000337	CcSEcCtD
Mirtazapine—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000337	CcSEcCtD
Mirtazapine—Tension—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000336	CcSEcCtD
Mirtazapine—Discomfort—Losartan—type 2 diabetes mellitus	4.64e-05	0.000336	CcSEcCtD
Mirtazapine—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000335	CcSEcCtD
Mirtazapine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.000335	CcSEcCtD
Mirtazapine—Headache—Bromocriptine—type 2 diabetes mellitus	4.62e-05	0.000335	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.62e-05	0.000334	CcSEcCtD
Mirtazapine—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.62e-05	0.000334	CcSEcCtD
Mirtazapine—Nervousness—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000333	CcSEcCtD
Mirtazapine—Dry mouth—Losartan—type 2 diabetes mellitus	4.59e-05	0.000333	CcSEcCtD
Mirtazapine—Anorexia—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.00033	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.55e-05	0.00033	CcSEcCtD
Mirtazapine—Paraesthesia—Metformin—type 2 diabetes mellitus	4.55e-05	0.00033	CcSEcCtD
Mirtazapine—Confusional state—Losartan—type 2 diabetes mellitus	4.54e-05	0.000329	CcSEcCtD
Mirtazapine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000328	CcSEcCtD
Mirtazapine—Dyspnoea—Metformin—type 2 diabetes mellitus	4.52e-05	0.000327	CcSEcCtD
Mirtazapine—Somnolence—Metformin—type 2 diabetes mellitus	4.51e-05	0.000326	CcSEcCtD
Mirtazapine—Oedema—Losartan—type 2 diabetes mellitus	4.5e-05	0.000326	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.5e-05	0.000326	CcSEcCtD
Mirtazapine—Infection—Losartan—type 2 diabetes mellitus	4.47e-05	0.000324	CcSEcCtD
Mirtazapine—Hypotension—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000324	CcSEcCtD
Mirtazapine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.46e-05	0.000323	CcSEcCtD
Mirtazapine—Dyspepsia—Metformin—type 2 diabetes mellitus	4.46e-05	0.000323	CcSEcCtD
Mirtazapine—Tremor—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000321	CcSEcCtD
Mirtazapine—Shock—Losartan—type 2 diabetes mellitus	4.43e-05	0.000321	CcSEcCtD
Mirtazapine—Urticaria—Valsartan—type 2 diabetes mellitus	4.42e-05	0.00032	CcSEcCtD
Mirtazapine—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.42e-05	0.00032	CcSEcCtD
Mirtazapine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.41e-05	0.000319	CcSEcCtD
Mirtazapine—Decreased appetite—Metformin—type 2 diabetes mellitus	4.41e-05	0.000319	CcSEcCtD
Mirtazapine—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000319	CcSEcCtD
Mirtazapine—Tachycardia—Losartan—type 2 diabetes mellitus	4.39e-05	0.000318	CcSEcCtD
Mirtazapine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000318	CcSEcCtD
Mirtazapine—Nausea—Bromocriptine—type 2 diabetes mellitus	4.38e-05	0.000318	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.38e-05	0.000317	CcSEcCtD
Mirtazapine—Fatigue—Metformin—type 2 diabetes mellitus	4.37e-05	0.000317	CcSEcCtD
Mirtazapine—Urticaria—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000316	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000316	CcSEcCtD
Mirtazapine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.35e-05	0.000315	CcSEcCtD
Mirtazapine—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000315	CcSEcCtD
Mirtazapine—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000315	CcSEcCtD
Mirtazapine—Asthenia—Gliclazide—type 2 diabetes mellitus	4.35e-05	0.000315	CcSEcCtD
Mirtazapine—Agitation—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000315	CcSEcCtD
Mirtazapine—Constipation—Metformin—type 2 diabetes mellitus	4.34e-05	0.000314	CcSEcCtD
Mirtazapine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000311	CcSEcCtD
Mirtazapine—Anorexia—Losartan—type 2 diabetes mellitus	4.29e-05	0.000311	CcSEcCtD
Mirtazapine—Vomiting—Glyburide—type 2 diabetes mellitus	4.29e-05	0.000311	CcSEcCtD
Mirtazapine—Pruritus—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.00031	CcSEcCtD
Mirtazapine—Malaise—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000309	CcSEcCtD
Mirtazapine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000309	CcSEcCtD
Mirtazapine—Rash—Glyburide—type 2 diabetes mellitus	4.25e-05	0.000308	CcSEcCtD
Mirtazapine—Somnolence—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000308	CcSEcCtD
Mirtazapine—Dermatitis—Glyburide—type 2 diabetes mellitus	4.25e-05	0.000308	CcSEcCtD
Mirtazapine—Vertigo—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000308	CcSEcCtD
Mirtazapine—Syncope—Ramipril—type 2 diabetes mellitus	4.24e-05	0.000307	CcSEcCtD
Mirtazapine—Leukopenia—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000307	CcSEcCtD
Mirtazapine—Headache—Glyburide—type 2 diabetes mellitus	4.23e-05	0.000306	CcSEcCtD
Mirtazapine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000305	CcSEcCtD
Mirtazapine—Hypotension—Losartan—type 2 diabetes mellitus	4.21e-05	0.000305	CcSEcCtD
Mirtazapine—Palpitations—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000303	CcSEcCtD
Mirtazapine—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.18e-05	0.000303	CcSEcCtD
Mirtazapine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000301	CcSEcCtD
Mirtazapine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000301	CcSEcCtD
Mirtazapine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.15e-05	0.0003	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.15e-05	0.0003	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000299	CcSEcCtD
Mirtazapine—Cough—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000299	CcSEcCtD
Mirtazapine—Fatigue—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000299	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.1e-05	0.000297	CcSEcCtD
Mirtazapine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000297	CcSEcCtD
Mirtazapine—Convulsion—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000297	CcSEcCtD
Mirtazapine—Constipation—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000296	CcSEcCtD
Mirtazapine—Pain—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000296	CcSEcCtD
Mirtazapine—Insomnia—Losartan—type 2 diabetes mellitus	4.07e-05	0.000295	CcSEcCtD
Mirtazapine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.05e-05	0.000293	CcSEcCtD
Mirtazapine—Paraesthesia—Losartan—type 2 diabetes mellitus	4.04e-05	0.000293	CcSEcCtD
Mirtazapine—Urticaria—Metformin—type 2 diabetes mellitus	4.03e-05	0.000292	CcSEcCtD
Mirtazapine—Chest pain—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000292	CcSEcCtD
Mirtazapine—Arthralgia—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000292	CcSEcCtD
Mirtazapine—Myalgia—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000292	CcSEcCtD
Mirtazapine—Dyspnoea—Losartan—type 2 diabetes mellitus	4.01e-05	0.000291	CcSEcCtD
Mirtazapine—Anxiety—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000291	CcSEcCtD
Mirtazapine—Nausea—Glyburide—type 2 diabetes mellitus	4.01e-05	0.00029	CcSEcCtD
Mirtazapine—Abdominal pain—Metformin—type 2 diabetes mellitus	4.01e-05	0.00029	CcSEcCtD
Mirtazapine—Dizziness—Gliclazide—type 2 diabetes mellitus	4.01e-05	0.00029	CcSEcCtD
Mirtazapine—Somnolence—Losartan—type 2 diabetes mellitus	4e-05	0.00029	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4e-05	0.00029	CcSEcCtD
Mirtazapine—Asthenia—Valsartan—type 2 diabetes mellitus	3.99e-05	0.000289	CcSEcCtD
Mirtazapine—Discomfort—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000288	CcSEcCtD
Mirtazapine—Dyspepsia—Losartan—type 2 diabetes mellitus	3.96e-05	0.000287	CcSEcCtD
Mirtazapine—Asthenia—Orlistat—type 2 diabetes mellitus	3.95e-05	0.000286	CcSEcCtD
Mirtazapine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000286	CcSEcCtD
Mirtazapine—Pruritus—Valsartan—type 2 diabetes mellitus	3.94e-05	0.000285	CcSEcCtD
Mirtazapine—Dry mouth—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000285	CcSEcCtD
Mirtazapine—Decreased appetite—Losartan—type 2 diabetes mellitus	3.91e-05	0.000283	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000283	CcSEcCtD
Mirtazapine—Confusional state—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000282	CcSEcCtD
Mirtazapine—Pruritus—Orlistat—type 2 diabetes mellitus	3.89e-05	0.000282	CcSEcCtD
Mirtazapine—Fatigue—Losartan—type 2 diabetes mellitus	3.88e-05	0.000281	CcSEcCtD
Mirtazapine—Oedema—Ramipril—type 2 diabetes mellitus	3.86e-05	0.00028	CcSEcCtD
Mirtazapine—Vomiting—Gliclazide—type 2 diabetes mellitus	3.85e-05	0.000279	CcSEcCtD
Mirtazapine—Pain—Losartan—type 2 diabetes mellitus	3.85e-05	0.000279	CcSEcCtD
Mirtazapine—Constipation—Losartan—type 2 diabetes mellitus	3.85e-05	0.000279	CcSEcCtD
Mirtazapine—Rash—Gliclazide—type 2 diabetes mellitus	3.82e-05	0.000277	CcSEcCtD
Mirtazapine—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.82e-05	0.000276	CcSEcCtD
Mirtazapine—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.81e-05	0.000276	CcSEcCtD
Mirtazapine—Urticaria—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000275	CcSEcCtD
Mirtazapine—Shock—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000275	CcSEcCtD
Mirtazapine—Headache—Gliclazide—type 2 diabetes mellitus	3.8e-05	0.000275	CcSEcCtD
Mirtazapine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000274	CcSEcCtD
Mirtazapine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000274	CcSEcCtD
Mirtazapine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000274	CcSEcCtD
Mirtazapine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000274	CcSEcCtD
Mirtazapine—Tachycardia—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000273	CcSEcCtD
Mirtazapine—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.76e-05	0.000273	CcSEcCtD
Mirtazapine—Skin disorder—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000272	CcSEcCtD
Mirtazapine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.73e-05	0.00027	CcSEcCtD
Mirtazapine—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.71e-05	0.000269	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.68e-05	0.000267	CcSEcCtD
Mirtazapine—Dizziness—Valsartan—type 2 diabetes mellitus	3.68e-05	0.000267	CcSEcCtD
Mirtazapine—Anorexia—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000266	CcSEcCtD
Mirtazapine—Dizziness—Orlistat—type 2 diabetes mellitus	3.64e-05	0.000263	CcSEcCtD
Mirtazapine—Asthenia—Metformin—type 2 diabetes mellitus	3.64e-05	0.000263	CcSEcCtD
Mirtazapine—Hypotension—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000261	CcSEcCtD
Mirtazapine—Nausea—Gliclazide—type 2 diabetes mellitus	3.6e-05	0.000261	CcSEcCtD
Mirtazapine—Pruritus—Metformin—type 2 diabetes mellitus	3.59e-05	0.00026	CcSEcCtD
Mirtazapine—Urticaria—Losartan—type 2 diabetes mellitus	3.58e-05	0.000259	CcSEcCtD
Mirtazapine—Abdominal pain—Losartan—type 2 diabetes mellitus	3.56e-05	0.000258	CcSEcCtD
Mirtazapine—Body temperature increased—Losartan—type 2 diabetes mellitus	3.56e-05	0.000258	CcSEcCtD
Mirtazapine—Vomiting—Valsartan—type 2 diabetes mellitus	3.54e-05	0.000256	CcSEcCtD
Mirtazapine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000255	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000255	CcSEcCtD
Mirtazapine—Rash—Valsartan—type 2 diabetes mellitus	3.51e-05	0.000254	CcSEcCtD
Mirtazapine—Dermatitis—Valsartan—type 2 diabetes mellitus	3.51e-05	0.000254	CcSEcCtD
Mirtazapine—Vomiting—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000253	CcSEcCtD
Mirtazapine—Insomnia—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000253	CcSEcCtD
Mirtazapine—Headache—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000253	CcSEcCtD
Mirtazapine—Diarrhoea—Metformin—type 2 diabetes mellitus	3.47e-05	0.000251	CcSEcCtD
Mirtazapine—Rash—Orlistat—type 2 diabetes mellitus	3.47e-05	0.000251	CcSEcCtD
Mirtazapine—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000251	CcSEcCtD
Mirtazapine—Dermatitis—Orlistat—type 2 diabetes mellitus	3.47e-05	0.000251	CcSEcCtD
Mirtazapine—Headache—Orlistat—type 2 diabetes mellitus	3.45e-05	0.00025	CcSEcCtD
Mirtazapine—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000249	CcSEcCtD
Mirtazapine—Asthenia—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000249	CcSEcCtD
Mirtazapine—Somnolence—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000249	CcSEcCtD
Mirtazapine—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000246	CcSEcCtD
Mirtazapine—Pruritus—Irbesartan—type 2 diabetes mellitus	3.38e-05	0.000245	CcSEcCtD
Mirtazapine—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000243	CcSEcCtD
Mirtazapine—Dizziness—Metformin—type 2 diabetes mellitus	3.35e-05	0.000243	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000241	CcSEcCtD
Mirtazapine—Fatigue—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000241	CcSEcCtD
Mirtazapine—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.32e-05	0.00024	CcSEcCtD
Mirtazapine—Nausea—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000239	CcSEcCtD
Mirtazapine—Constipation—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000239	CcSEcCtD
Mirtazapine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000237	CcSEcCtD
Mirtazapine—Nausea—Orlistat—type 2 diabetes mellitus	3.27e-05	0.000237	CcSEcCtD
Mirtazapine—Asthenia—Losartan—type 2 diabetes mellitus	3.23e-05	0.000234	CcSEcCtD
Mirtazapine—Vomiting—Metformin—type 2 diabetes mellitus	3.22e-05	0.000233	CcSEcCtD
Mirtazapine—Rash—Metformin—type 2 diabetes mellitus	3.2e-05	0.000231	CcSEcCtD
Mirtazapine—Dermatitis—Metformin—type 2 diabetes mellitus	3.19e-05	0.000231	CcSEcCtD
Mirtazapine—Pruritus—Losartan—type 2 diabetes mellitus	3.19e-05	0.000231	CcSEcCtD
Mirtazapine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.18e-05	0.00023	CcSEcCtD
Mirtazapine—Headache—Metformin—type 2 diabetes mellitus	3.18e-05	0.00023	CcSEcCtD
Mirtazapine—Dizziness—Irbesartan—type 2 diabetes mellitus	3.16e-05	0.000229	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000229	CcSEcCtD
Mirtazapine—Diarrhoea—Losartan—type 2 diabetes mellitus	3.08e-05	0.000223	CcSEcCtD
Mirtazapine—Urticaria—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000222	CcSEcCtD
Mirtazapine—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000221	CcSEcCtD
Mirtazapine—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000221	CcSEcCtD
Mirtazapine—Vomiting—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.00022	CcSEcCtD
Mirtazapine—Rash—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000218	CcSEcCtD
Mirtazapine—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.01e-05	0.000218	CcSEcCtD
Mirtazapine—Nausea—Metformin—type 2 diabetes mellitus	3.01e-05	0.000218	CcSEcCtD
Mirtazapine—Headache—Irbesartan—type 2 diabetes mellitus	3e-05	0.000217	CcSEcCtD
Mirtazapine—Dizziness—Losartan—type 2 diabetes mellitus	2.98e-05	0.000216	CcSEcCtD
Mirtazapine—Vomiting—Losartan—type 2 diabetes mellitus	2.86e-05	0.000207	CcSEcCtD
Mirtazapine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000206	CcSEcCtD
Mirtazapine—Nausea—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000206	CcSEcCtD
Mirtazapine—Rash—Losartan—type 2 diabetes mellitus	2.84e-05	0.000206	CcSEcCtD
Mirtazapine—Dermatitis—Losartan—type 2 diabetes mellitus	2.84e-05	0.000205	CcSEcCtD
Mirtazapine—Headache—Losartan—type 2 diabetes mellitus	2.82e-05	0.000204	CcSEcCtD
Mirtazapine—Asthenia—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000201	CcSEcCtD
Mirtazapine—Pruritus—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000198	CcSEcCtD
Mirtazapine—Nausea—Losartan—type 2 diabetes mellitus	2.67e-05	0.000194	CcSEcCtD
Mirtazapine—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000191	CcSEcCtD
Mirtazapine—Dizziness—Ramipril—type 2 diabetes mellitus	2.55e-05	0.000185	CcSEcCtD
Mirtazapine—Vomiting—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000178	CcSEcCtD
Mirtazapine—Rash—Ramipril—type 2 diabetes mellitus	2.43e-05	0.000176	CcSEcCtD
Mirtazapine—Dermatitis—Ramipril—type 2 diabetes mellitus	2.43e-05	0.000176	CcSEcCtD
Mirtazapine—Headache—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000175	CcSEcCtD
Mirtazapine—Nausea—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000166	CcSEcCtD
Mirtazapine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.34e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.33e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.32e-06	1.5e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.32e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.31e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.31e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.31e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.31e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.3e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.3e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.3e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.3e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.3e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	1.47e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.29e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.29e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.29e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.28e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.27e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.26e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.26e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.26e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.25e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.25e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.25e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.24e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.24e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.24e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.24e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.24e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.23e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.23e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.23e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.23e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.23e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.22e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.22e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.22e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.22e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.21e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.2e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.2e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.19e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.18e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.17e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.17e-06	1.33e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.17e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.14e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	1.29e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-06	1.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.13e-06	1.29e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.13e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.12e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-06	1.25e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-06	1.23e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.08e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-06	1.22e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.06e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.05e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.05e-06	1.2e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.05e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.04e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.04e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.04e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.04e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.02e-06	1.16e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-06	1.15e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.01e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.01e-06	1.14e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.99e-07	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.99e-07	1.13e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.96e-07	1.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.91e-07	1.12e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.91e-07	1.12e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.79e-07	1.11e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.78e-07	1.11e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.77e-07	1.11e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.71e-07	1.1e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	9.69e-07	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.64e-07	1.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.64e-07	1.09e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.62e-07	1.09e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.6e-07	1.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.6e-07	1.09e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	9.56e-07	1.08e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.53e-07	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.5e-07	1.08e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.49e-07	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.45e-07	1.07e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.42e-07	1.07e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.4e-07	1.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.4e-07	1.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.37e-07	1.06e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.37e-07	1.06e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.35e-07	1.06e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.34e-07	1.06e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.25e-07	1.05e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.23e-07	1.05e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.23e-07	1.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.21e-07	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.18e-07	1.04e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	9.15e-07	1.04e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	9.15e-07	1.04e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9.13e-07	1.03e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	9.09e-07	1.03e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.01e-07	1.02e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.94e-07	1.01e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.91e-07	1.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.76e-07	9.93e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.74e-07	9.91e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.65e-07	9.8e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.61e-07	9.76e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.6e-07	9.75e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.59e-07	9.73e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.57e-07	9.72e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.54e-07	9.68e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.53e-07	9.67e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.48e-07	9.62e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.44e-07	9.57e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.44e-07	9.56e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.42e-07	9.55e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.42e-07	9.54e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	8.36e-07	9.48e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.26e-07	9.36e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.22e-07	9.32e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	8.17e-07	9.26e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.08e-07	9.16e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.05e-07	9.13e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	8.01e-07	9.08e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.96e-07	9.02e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.94e-07	9.01e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.85e-07	8.9e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.83e-07	8.87e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.82e-07	8.86e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.82e-07	8.86e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.68e-07	8.7e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.68e-07	8.7e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.5e-07	8.51e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.47e-07	8.46e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.26e-07	8.23e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.24e-07	8.21e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.15e-07	8.1e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.08e-07	8.03e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.01e-07	7.95e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.92e-07	7.85e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.89e-07	7.81e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.88e-07	7.8e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.7e-07	7.6e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.59e-07	7.47e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	6.51e-07	7.38e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.48e-07	7.35e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.47e-07	7.33e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.35e-07	7.2e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.31e-07	7.15e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.08e-07	6.89e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.03e-07	6.84e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.03e-07	6.84e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.98e-07	6.78e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.97e-07	6.77e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.9e-07	6.69e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.86e-07	6.64e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.52e-07	6.25e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.44e-07	6.17e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	5.17e-07	5.86e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.24e-07	4.81e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	4.2e-07	4.77e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.59e-07	4.07e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.77e-07	3.14e-06	CbGpPWpGaD
